Published in J Immigr Minor Health on October 01, 2011
Electronic messages increase hepatitis B screening in at-risk Asian American patients: a randomized, controlled trial. Dig Dis Sci (2012) 1.03
Novel aspects of the liver microenvironment in hepatocellular carcinoma pathogenesis and development. Int J Mol Sci (2014) 0.89
Clinical presentation and survival of Asian and non-Asian patients with HCV-related hepatocellular carcinoma. Dig Dis Sci (2013) 0.87
Hepatitis B- and hepatitis C-related hepatocellular carcinomas in the United States: similarities and differences. Hepat Mon (2012) 0.87
Viral genotypes and associated risk factors of hepatocellular carcinoma in India. Cancer Biol Med (2012) 0.84
Reversible phospho-Smad3 signalling between tumour suppression and fibrocarcinogenesis in chronic hepatitis B infection. Clin Exp Immunol (2014) 0.83
Hepatic encephalopathy associated with cancer or anticancer therapy. Gastrointest Cancer Res (2013) 0.83
Racial disparities in treatment and survival of patients with hepatocellular carcinoma in the United States. Hepatobiliary Surg Nutr (2016) 0.80
Accumulation of Deleterious Passenger Mutations Is Associated with the Progression of Hepatocellular Carcinoma. PLoS One (2016) 0.75
Methodological assessment of HCC literature. Ann Oncol (2013) 0.75
Correlation between the expression of hTERT gene and the clinicopathological characteristics of hepatocellular carcinoma. Oncol Lett (2015) 0.75
Management of hepatocellular carcinoma. Hepatology (2005) 27.42
Hepatocellular carcinoma. Lancet (2003) 22.54
Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med (1999) 17.03
A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology (2000) 9.74
Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients. Cancer (1985) 7.67
Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease. Gastroenterology (2008) 6.15
The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update. Ann Intern Med (2003) 6.06
Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients. Gastroenterology (1997) 5.53
Annual report to the nation on the status of cancer, 1975-2003, featuring cancer among U.S. Hispanic/Latino populations. Cancer (2006) 4.71
Resection and liver transplantation for hepatocellular carcinoma. Semin Liver Dis (2005) 4.51
Epidemiology of primary liver cancer. Semin Liver Dis (1999) 4.48
Epidemiology of hepatocellular carcinoma. Clin Liver Dis (2005) 4.29
Hepatitis C: global prevalence. Wkly Epidemiol Rec (1997) 3.95
Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases. Cancer (2005) 3.69
Prospective validation of the CLIP score: a new prognostic system for patients with cirrhosis and hepatocellular carcinoma. The Cancer of the Liver Italian Program (CLIP) Investigators. Hepatology (2000) 3.30
Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: a population-based study. Gastroenterology (2004) 3.30
A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma. Gastroenterology (2005) 3.26
Alcohol and hepatocellular carcinoma: the effect of lifetime intake and hepatitis virus infections in men and women. Am J Epidemiol (2002) 2.94
Hepatocellular carcinoma in the United States. Prognostic features, treatment outcome, and survival. Cancer (1996) 2.26
Natural history of hepatitis-related hepatocellular carcinoma. World J Gastroenterol (2008) 2.24
Hepatitis C-related hepatocellular carcinoma in the United States: influence of ethnic status. Am J Gastroenterol (2003) 2.18
Hepatitis B virus (HBV) infection in Asian and Pacific Islander Americans (APIAs): how can we do better for this special population? Am J Gastroenterol (2008) 1.89
Racial differences in survival of hepatocellular carcinoma in the United States: a population-based study. Clin Gastroenterol Hepatol (2006) 1.72
Provider knowledge and practice regarding hepatitis B screening in Chinese-speaking patients. J Cancer Educ (2007) 1.55
Utility of a discriminant score for diagnosing advanced fibrosis or cirrhosis in patients with chronic hepatitis C virus infection. Am J Gastroenterol (1997) 1.39
Epidemiology of hepatocellular carcinoma. Toxicology (2002) 1.38
Racial and ethnic variations in hepatocellular carcinoma incidence within the United States. Am J Med (2008) 1.38
Evaluation of hepatitis B and C viral markers: clinical significance in Asian and Caucasian patients with hepatocellular carcinoma in the United States of America. J Gastroenterol Hepatol (1996) 1.21
Hepatitis B and C viruses in the development of hepatocellular carcinoma. Crit Rev Oncol Hematol (1994) 1.17
Factors associated with hepatic fibrosis in patients with chronic hepatitis C: a retrospective study of a large cohort of U.S. patients. J Clin Gastroenterol (2009) 0.96
Survival and hepatitis status among Asian Americans with hepatocellular carcinoma treated without liver transplantation. BMC Cancer (2009) 0.95
Ethnic differences in the behavior of hepatocellular carcinoma. Cancer (1999) 0.95
Geographic variation within the United States in the incidence of hepatocellular carcinoma. J Clin Epidemiol (2003) 0.93
Survival in Asian Americans after treatments for hepatocellular carcinoma: a seven-year experience at UCLA. J Clin Gastroenterol (2010) 0.92
Hepatitis B and alcohol affect survival of hepatocellular carcinoma patients. World J Gastroenterol (2005) 0.91
Accuracy of clinical criteria for the diagnosis of hepatocellular carcinoma without biopsy in a Hepatitis B virus-endemic area. J Cancer Res Clin Oncol (2007) 0.90
Hepatitis C virus 1b, cirrhosis, and hepatocellular carcinoma. Hepatology (1997) 0.82
Treatment of hepatocellular carcinoma. Indian J Gastroenterol (2008) 0.78
Prospective multicenter study of eligibility for antiviral therapy among 4,084 U.S. veterans with chronic hepatitis C virus infection. Am J Gastroenterol (2005) 3.09
Multicenter randomized controlled trial of percutaneous cryoablation versus radiofrequency ablation in hepatocellular carcinoma. Hepatology (2015) 2.81
Serum cholesterol and statin use predict virological response to peginterferon and ribavirin therapy. Hepatology (2010) 2.53
Surgery for gallstone ileus: a nationwide comparison of trends and outcomes. Ann Surg (2014) 2.25
MELD score is a better prognostic model than Child-Turcotte-Pugh score or Discriminant Function score in patients with alcoholic hepatitis. J Hepatol (2005) 2.21
Severe intraoperative hyperglycemia is independently associated with surgical site infection after liver transplantation. Transplantation (2009) 1.65
Predictors of hyperkalemia in the prereperfusion, early postreperfusion, and late postreperfusion periods during adult liver transplantation. Anesth Analg (2007) 1.57
Liver transplantation for nonalcoholic steatohepatitis: the new epidemic. Ann Surg (2012) 1.55
Use of Seamguard to prevent pancreatic leak following distal pancreatectomy. Arch Surg (2009) 1.53
Prevalence of metastases in hepatocellular carcinoma: risk factors and impact on survival. Am Surg (2003) 1.37
Hepatic artery pseudoaneurysm: a report of seven cases and a review of the literature. Surg Today (2005) 1.34
Octreotide/Midodrine therapy significantly improves renal function and 30-day survival in patients with type 1 hepatorenal syndrome. Dig Dis Sci (2007) 1.13
Quantification and mechanisms of oleic acid-induced steatosis in HepG2 cells. Am J Transl Res (2010) 1.10
The evolution of liver transplantation during 3 decades: analysis of 5347 consecutive liver transplants at a single center. Ann Surg (2013) 1.08
Metronomic gemcitabine in combination with sunitinib inhibits multisite metastasis and increases survival in an orthotopic model of pancreatic cancer. Mol Cancer Ther (2010) 1.07
In vitro and in vivo effects and mechanisms of celecoxib-induced growth inhibition of human hepatocellular carcinoma cells. Clin Cancer Res (2005) 1.04
Effects and mechanisms of silibinin on human hepatoma cell lines. World J Gastroenterol (2007) 1.02
Can we predict the degree of fibrosis in chronic hepatitis C patients using routine blood tests in our daily practice? J Clin Gastroenterol (2008) 0.99
Fatal variceal rupture after sildenafil use: report of a case. Curr Surg (2005) 0.99
Nephrogenic fibrosing dermopathy after liver transplantation successfully treated with plasmapheresis. Am J Dermatopathol (2003) 0.99
Hepatitis C virus (HCV) infection and hepatic steatosis. Int J Med Sci (2006) 0.98
Preoperative characteristics and intraoperative transfusion and vasopressor requirements in patients with low vs. high MELD scores. Liver Transpl (2006) 0.97
Factors associated with hepatic fibrosis in patients with chronic hepatitis C: a retrospective study of a large cohort of U.S. patients. J Clin Gastroenterol (2009) 0.96
Long-term therapy with nucleoside/nucleotide analogues for chronic hepatitis B in Asian patients. Antivir Ther (2012) 0.95
High intratumoral metastasis-associated in colon cancer-1 expression predicts poor outcomes of cryoablation therapy for advanced hepatocellular carcinoma. J Transl Med (2013) 0.94
Adenosquamous versus adenocarcinoma of the pancreas: a population-based outcomes analysis. J Gastrointest Surg (2010) 0.93
Postliver transplant acute renal injury and failure by the RIFLE criteria in patients with normal pretransplant serum creatinine concentrations: a matched study. Transplantation (2011) 0.88
Carcinoid tumors of the common bile duct: report of two cases. Surg Today (2003) 0.88
Associated vascular injury in patients with bile duct injury during cholecystectomy. Am Surg (2011) 0.87
Update on rescue therapies in patients with lamivudine-resistant chronic hepatitis B. Drug Des Devel Ther (2013) 0.87
Effects and mechanisms of silibinin on human hepatocellular carcinoma xenografts in nude mice. World J Gastroenterol (2009) 0.87
Fatal spontaneous gallbladder variceal bleeding in a patient with alcoholic cirrhosis. Dig Dis Sci (2002) 0.87
Prevalence and presentation of hepatitis B and C virus (HBV and HCV) infection in Vietnamese Americans via serial community serologic testing. J Immigr Minor Health (2015) 0.86
Insulin therapy in divided doses coupled with blood transfusion versus large bolus doses in patients at high risk for hyperkalemia during liver transplantation. J Cardiothorac Vasc Anesth (2009) 0.85
Endoscopic ultrasound-guided fine-needle aspiration of undifferentiated carcinoma with osteoclast-like giant cells of the pancreas: a report of 2 cases with literature review. Diagn Cytopathol (2007) 0.84
Regulated hepatic reperfusion mitigates ischemia-reperfusion injury and improves survival after prolonged liver warm ischemia: a pilot study on a novel concept of organ resuscitation in a large animal model. J Am Coll Surg (2012) 0.84
Use of Yttrium-90 TheraSphere for the treatment of unresectable hepatocellular carcinoma. Am Surg (2004) 0.81
Advances in managing hepatocellular carcinoma. Front Med (2014) 0.80
Multidisciplinary management of resectable adenocarcinoma of the pancreatic head. Expert Rev Anticancer Ther (2008) 0.80
Cystic pancreatic neoplasm in pregnancy: a case report and review of the literature. Arch Surg (2008) 0.80
The influence of organ acceptance criteria on long-term graft survival: outcomes of a kidney transplant program. Am J Surg (2008) 0.79
Improvement in liver histology among Asian patients with chronic hepatitis B after long-term treatment with entecavir. Liver Int (2013) 0.79
A practical approach to managing patients with HCV infection. Int J Med Sci (2006) 0.79
Avoiding Futility in Simultaneous Liver-kidney Transplantation: Analysis of 331 Consecutive Patients Listed for Dual Organ Replacement. Ann Surg (2017) 0.79
Current hepatitis B treatment guidelines and future research directions. Front Med (2014) 0.78
Farnesyltransferase inhibition: a novel method of immunomodulation. Int Immunopharmacol (2003) 0.78
Potent farnesyltransferase inhibitor ABT-100 abrogates acute allograft rejection. J Heart Lung Transplant (2005) 0.78
The clinical presentation of chronic hepatitis B virus infection in Asian Americans: a single center retrospective study. J Clin Gastroenterol (2010) 0.78
Clinical presentation and disease phases of chronic hepatitis B using conventional versus modified ALT criteria in Asian Americans. Dig Dis Sci (2014) 0.78
Prevention of chronic rejection by pravastatin in a rat kidney transplant model. Transplantation (2002) 0.77
Evolution in the Treatment of Delayed Postpancreatectomy Hemorrhage: Surgery to Interventional Radiology. Pancreas (2015) 0.77
Boceprevir plus peginterferon α-2b/ribavirin in chronic hepatitis C genotype 1: impact of baseline viral load on sustained virologic response. J Clin Gastroenterol (2014) 0.77
Immunomodulatory effects of docetaxel on human lymphocytes. Invest New Drugs (2003) 0.77
Charcoal-based hemodiabsorption liver support for episodic type C hepatic encephalopathy. Am J Gastroenterol (2003) 0.76
In-vivo effects and mechanisms of celecoxib-reduced growth of cyclooxygenase-2 (COX-2)-expressing versus COX-2-deleted human HCC xenografts in nude mice. Anticancer Drugs (2008) 0.76
Hepatitis B immunoglobulin in preventing reinfection following liver transplantation. Expert Rev Anti Infect Ther (2009) 0.76
Intraoperative hypokalemia in pediatric liver transplantation: incidence and risk factors. Anesth Analg (2006) 0.76
High rates of viral suppression after long-term entecavir treatment of Asian patients with hepatitis B e antigen-positive chronic hepatitis B. Clin Gastroenterol Hepatol (2012) 0.75
Giant choledochal cyst mimicking massive gallbladder hydrops in an adult patient: multi detector computed tomography and magnetic resonance imaging findings correlated to gross and histopathological findings. J Clin Imaging Sci (2013) 0.75
Gd-EOB-DTPA-Enhanced MRI for Detection of Liver Metastases from Colorectal Cancer: A Surgeon's Perspective! Int J Hepatol (2013) 0.75
Protective effect of an improved immunization practice of mother-to-infant transmission of hepatitis B virus and risk factors associated with immunoprophylaxis failure. Medicine (Baltimore) (2016) 0.75
Validation of revised American Joint Committee on Cancer staging for gallbladder cancer based on a single institution experience. Am Surg (2013) 0.75
Pneumatosis in post-Whipple patients. Am Surg (2012) 0.75
Guest editor's editorial: Advances in managing hepatitis C virus (HCV) infection (A special issue). Int J Med Sci (2006) 0.75
Use of Vascular Clamping in Hepatic Surgery: Lessons Learned From 1260 Liver Resections-Invited Critique. Arch Surg (2008) 0.75
Endoscopic versus surgical treatment of downstream pancreatic duct stones in chronic pancreatitis. Am Surg (2011) 0.75
Hepatobiliary manifestations of gastrointestinal and nutritional disorders. Clin Liver Dis (2011) 0.75
Massive congenital choledocal cyst. Liver Int (2013) 0.75
Formal heparin anticoagulation protocol improves safety of charcoal-based liver-assist treatments. ASAIO J (2006) 0.75
Preface. Hepatobiliary manifestations of systemic diseases. Clin Liver Dis (2011) 0.75
New perspective on the natural course of chronic HBV infection. Front Med (2014) 0.75